Open AccessAssociation Study Between Promoter Polymorphisms of ADAM17 and Progression of Sepsis
Author(s) -
Yiming Shao,
Junbing He,
Feng Chen,
Yujie Cai,
Jianghao Zhao,
Yao Lin,
Zihan Yin,
Hua Tao,
Xin Shao,
Pengru Huang,
Mingkang Yin,
Wenying Zhang,
Zhou Liu,
Lili Cui
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000447830
Subject(s) - sepsis , genotyping , genotype , pathogenesis , immunology , clinical significance , medicine , tumor necrosis factor alpha , biology , genetics , gene
A disintegrin and metalloproteinase 17 (ADAM17) has been confirmed to play a significant role in the pathogenesis of sepsis. However, little is known about the clinical relevance of ADAM17 polymorphisms to sepsis onset and development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom